On 20 September, the three-year Coordination and Support Action “Neuronet” announced the launch of its first newsletter issue and the start of a Twitter campaign to explain why they do what they do. This and the future newsletter issues will introduce you to our fantastic early-career researchers and investigators, project achievements as well as our activities. You can read the online version of the newsletter here: http://bit.ly/Neuronet-newsletter-1
Neuronet sets out to boost collaboration across the Innovative Medicines Initiative (IMI) projects of the Neurodegenerative Disorders (ND) portfolio, assisting in identifying gaps, multiplying its impact, enhancing its visibility and facilitating dovetailing with related initiatives in Europe and worldwide.
Neuronet's communication team and its community of communication representatives from the IMI projects on neurodegeneration are pleased to announce that they will celebrate the great people behind their projects.
Each day, one of the researchers respectively participants from the Innovative Medicines Initiative projects will speak up. They will link to some of the great findings, interesting activities and tools, none of which would have been possible without public-private collaboration. Follow them on Twitter so that you can keep up to date with the series and keep an eye on #WeAreNeuronet: https://twitter.com/IMI2_NEURONET
